Aeluma (NASDAQ:ALMU) Announces Quarterly Earnings Results

Aeluma (NASDAQ:ALMU) released its quarterly earnings data on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, FiscalAI reports. Aeluma had a negative net margin of 205.31% and a negative return on equity of 19.96%. The company had revenue of $0.58 million during the quarter.

Here are the key takeaways from Aeluma’s conference call:

• Aeluma is prioritizing commercialization in AI datacom, focusing on its Lynx high-speed photodetectors and Quasar quantum-dot lasers for scale-up and scale-out data-center interconnects. Management cited strong anticipated industry demand and customer interest driven by photonics supply constraints.
• The company signed an agreement with Sumitomo Chemical Advanced Technologies to expand wafer-production capacity and plans to install multiple AIXTRON MOCVD systems, supporting higher-volume manufacturing of its non-indium-phosphide technologies.
• Aeluma is negotiating several multimillion-dollar commercial NRE programs, primarily with top-tier AI-datacom customers. It also has a letter of intent for up to $30 million in CHIPS R&D funding, which management expects would accelerate commercialization, although the funding would likely be recorded as a government equity investment rather than revenue.
• Fiscal 2026 revenue was $4.5 million, roughly flat year over year, while the GAAP net loss widened to $9.2 million from $3.0 million as headcount and operating expenses increased. Fiscal 2027 booked government-contract revenue is expected to be approximately $2.3 million, with additional revenue uncertain.
• Aeluma ended the year with $56 million in cash and no debt after raising $20.1 million through its ATM facility, but expects to spend approximately $10 million–$12 million in fiscal 2027 capital expenditures on MOCVD equipment and manufacturing scale-up.

Aeluma Stock Down 14.0%

Shares of ALMU stock opened at $11.55 on Friday. The stock’s 50-day moving average price is $15.10 and its 200 day moving average price is $17.95. The stock has a market capitalization of $211.42 million, a PE ratio of -22.21 and a beta of 4.07. Aeluma has a 52-week low of $10.24 and a 52-week high of $31.79.

Key Stories Impacting Aeluma

Here are the key news stories impacting Aeluma this week:

• Positive Sentiment: Freedom Broker maintained a Buy rating while lowering its price target from $30 to $25. The revised target still implies substantial upside from recent levels, suggesting the broker views the selloff as excessive. Benzinga analyst rating report
• Positive Sentiment: Aeluma signed a letter of intent for up to $30 million in CHIPS Act funding tied to artificial intelligence and advanced computing, potentially helping finance expansion. The company also expanded its strategic relationship with Sumitomo Chemical Advanced Technologies, including plans to increase wafer capacity. Aeluma fiscal 2026 results and strategic announcements
• Positive Sentiment: The company ended the period with approximately $56 million in cash and is pursuing commercialization in photonics, AI, defense, aerospace and quantum applications. Analysts continue to hold a Moderate Buy consensus despite near-term losses. Aeluma selloff and commercialization outlook
• Neutral Sentiment: Management plans approximately $10 million to $12 million in fiscal 2027 capital expenditures. This spending could support growth, but it also increases execution and funding requirements before revenue scales. Aeluma CHIPS funding and fiscal 2027 capital plans
• Negative Sentiment: Fiscal fourth-quarter revenue was only $0.58 million, while adjusted earnings were a loss of $0.15 per share. A negative net margin of 115.57% and negative return on equity highlighted continuing operating losses, contributing to the stock’s decline. Aeluma fiscal 2026 earnings report
• Negative Sentiment: The company’s wider losses and early-stage revenue profile leave investors dependent on successful commercialization, customer adoption and future funding support. Aeluma’s high beta also indicates elevated share-price volatility. Aeluma fiscal 2026 earnings call transcript

Wall Street Analyst Weigh In

A number of analysts recently issued reports on ALMU shares. Freedom Broker decreased their target price on Aeluma from $30.00 to $25.00 and set a “buy” rating for the company in a research report on Thursday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aeluma in a research report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Aeluma currently has a consensus rating of “Moderate Buy” and a consensus target price of $25.00.

Insider Buying and Selling at Aeluma

In other Aeluma news, Director Steven Denbaars sold 12,500 shares of Aeluma stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $13.84, for a total value of $173,000.00. Following the transaction, the director directly owned 357,709 shares in the company, valued at approximately $4,950,692.56. This trade represents a 3.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 14.70% of the company’s stock.

Aeluma Company Profile

Aeluma, Inc is a semiconductor company that develops and manufactures high-performance components for communications, sensing, computing and other advanced technology applications. The company’s technology is designed to support the production of semiconductor devices on large-area and nontraditional substrates, with the goal of improving performance, scalability and integration.

Aeluma’s products and development efforts include photonic and optoelectronic components such as photodetectors and related devices used in optical communications, data centers, 3D sensing, artificial intelligence, aerospace and defense, automotive systems, and consumer electronics.